Exomic Sequencing of Four Rare Central Nervous System Tumor Types

Chetan Bettegowda; Nishant Agrawal; Yuchen Jiao; Yuxuan Wang; Laura D. Wood; Fausto J. Rodriguez; Ralph H. Hruban; Gary L. Gallia; Zev A. Binder; Callen J. Riggins; Vafi Salmasi; Gregory J. Riggins; Zachary J. Reitman; Ahmed Rasheed; Stephen Keir; Sueli Shinjo; Suely Marie; Roger McLendon; George Jallo; Bert Vogelstein; Darrell Bigner; Hai Yan; Kenneth W. Kinzler; Nickolas Papadopoulos

doi:10.18632/oncotarget.964

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers:

Exomic Sequencing of Four Rare Central Nervous System Tumor Types

Chetan Bettegowda _, Nishant Agrawal, Yuchen Jiao, Yuxuan Wang, Laura D. Wood, Fausto J. Rodriguez, Ralph H. Hruban, Gary L. Gallia, Zev A. Binder, Callen J. Riggins, Vafi Salmasi, Gregory J. Riggins, Zachary J. Reitman, Ahmed Rasheed, Stephen Keir, Sueli Shinjo, Suely Marie, Roger McLendon, George Jallo, Bert Vogelstein, Darrell Bigner, Hai Yan, Kenneth W. Kinzler and Nickolas Papadopoulos

PDF | HTML | Supplementary Files | How to cite

Oncotarget. 2013; 4:572-583. https://doi.org/10.18632/oncotarget.964

Metrics: PDF 3606 views | HTML 3979 views | ?

Abstract

Chetan Bettegowda1,2,*, Nishant Agrawal2,3,*, Yuchen Jiao2,*, Yuxuan Wang2, Laura D. Wood4, Fausto J. Rodriguez4, Ralph H. Hruban4, Gary L. Gallia1, Zev A. Binder1, Callen J. Riggins1, Vafi Salmasi5, Gregory J. Riggins1, Zachary J. Reitman6, Ahmed Rasheed6, Stephen Keir6, Sueli Shinjo7, Suely Marie7, Roger McLendon6, George Jallo1, Bert Vogelstein2, Darell Bigner6, Hai Yan6, Kenneth W. Kinzler2 and Nickolas Papadopoulos2

1 Department of Neurosurgery, Johns Hopkins University School of Medicine, Baltimore, MD, USA

2 Ludwig Center for Cancer Genetics, Johns Hopkins University School of Medicine, Baltimore, MD, USA

3 Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins University School of Medicine, Baltimore, MD, USA

4 Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD USA

5 Department of Anesthesiology, Cleveland Clinic Hospital, Cleveland, OH USA

6 Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, NC, USA

7 Department of Pathology, University of São Paulo School of Medicine, São Paulo, Brazil

* C.B., N.A. and Y.J. contributed equally as first authors.

Correspondence:

Chetan Bettegowda , email:

Kenneth W. Kinzler , email:

Nickolas Papadopoulos , email:

Keywords: Central nervous system (CNS) tumors, cancer genetics, exome sequencing, pediatric tumors, brain tumors.

Received: April 4, 2013 Accepted: April 6, 2013 Published: April 6, 2013

Abstract

A heterogeneous population of uncommon neoplasms of the central nervous system (CNS) cause significant morbidity and mortality. To explore their genetic origins, we sequenced the exomes of 12 pleomorphic xanthoastrocytomas (PXA), 17 non-brainstem pediatric glioblastomas (PGBM), 8 intracranial ependymomas (IEP) and 8 spinal cord ependymomas (SCEP). Analysis of the mutational spectra revealed that the predominant single base pair substitution was a C:G>T:A transition in each of the four tumor types. Our data confirm the critical roles of several known driver genes within CNS neoplasms, including TP53 and ATRX in PGBM, and NF2 in SCEPs. Additionally, we show that activating BRAF mutations play a central role in both low and high grade glial tumors. Furthermore, alterations in genes coding for members of the mammalian target of rapamycin (mTOR) pathway were observed in 33% of PXA. Our study supports the hypothesis that pathologically similar tumors arising in different age groups and from different compartments may represent distinct disease processes with varied genetic composition.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 964

Publication Alerts

Research Papers:

Exomic Sequencing of Four Rare Central Nervous System Tumor Types

Abstract